A Day to Remember
I remember a June day in my family’s Seoul apartment when I was in a celebratory mood following my college graduation. It was a day… Read More »A Day to Remember
I remember a June day in my family’s Seoul apartment when I was in a celebratory mood following my college graduation. It was a day… Read More »A Day to Remember
This blog is a collaboration between medical students Vennela Avula and Ariel Vilidnitsky. As part of the Global Health Leadership Program at the Johns Hopkins… Read More »Insights from a Global Health Rotation in Peru
Last May, the National Oceanic and Atmospheric Administration (NOAA) published a notice predicting an increase in the number of hurricanes in the Atlantic for the… Read More »Hurricanes Milton and Helene Visit Florida: A Post Doc’s Perspective
Something I unexpectedly learned about myself this year: I love to dress up. It started with a Twilight watch party that one of my classmates… Read More »Dressing Up the Days
Mentorship has been pivotal in shaping my medical journey, providing invaluable guidance, inspiration and opportunities for growth. As a physician in training, I’ve been fortunate… Read More »The Power of Mentorship
Baltimore is a hub of scientific innovation, boasting three major biomedical research institutions — The Johns Hopkins University (JHU); the University of Maryland, Baltimore; and… Read More »From Labs to Locals: Zine Promotes Science Accessibility in Baltimore
“No worries. If you feel unsafe, you can use us anytime. That’s why we are here for.” It was late at night, a time when… Read More »Connection and Kindness in a New Place
This article has been de-identified to protect the anonymity and confidentiality of the patient in the story. Any matches in names or circumstances to… Read More »A Lingering Question, A Fading Heartbeat
In 2021 and 2023, the FDA approved Wegovy (semaglutide) and Zepbound (tirzapatide), respectively, for chronic weight management, along with increased physical activity and a reduced… Read More »New Published Study Maps Risks and Benefits Associated with Glucagon-Like Peptide 1 Receptor Agonist Use